INHIBITORS
Clinical trials for INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new INHIBITORS trials appear
Sign up with your email to follow new studies for INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hemophilia a patients with inhibitors: PCC trial targets bleeding episodes
Disease control Recruiting nowThis study tests a medicine called prothrombin complex concentrate (PCC) to stop bleeding episodes in people with hemophilia A who have developed inhibitors (antibodies that block standard treatment). Thirty participants aged 12 to 65 will receive PCC on-demand during bleeding, w…
Matched conditions: INHIBITORS
Phase: PHASE4 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New study tracks hemophilia a risks in mothers and babies
Knowledge-focused Recruiting nowThis study follows 500 mother-child pairs where the mother has a severe hemophilia A gene. It aims to understand bleeding risks during pregnancy and childbirth for mothers, and how children develop antibodies to factor VIII treatment. By observing families over time, researchers …
Matched conditions: INHIBITORS
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC